Drug intelligence / Profile preview

[64Cu] Macrin

Development stage
Phase 1
Lead developer
Ralph Weissleder, MD
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

[64Cu] Macrin is a diagnostic radiopharmaceutical consisting of a 64Cu-labeled polyglucose nanoparticle designed for quantitative positron emission tomography (PET) imaging of macrophages. It selectively accumulates in macrophages with >90% specificity, allowing for non-invasive visualization and quantification of macrophage distribution in tissues. The radioactive half-life of 64Cu (12.7 hours) enables imaging at 24 hours post-injection, providing high signal-to-noise imaging of macrophage uptake. This makes it particularly useful for detecting inflammatory "hotspots" and quantifying local macrophage density in various conditions. [64Cu] Macrin differs from previous cross-linked dextran nanoparticles in that all components are biodegradable and safe, with L-lysine used as the crosslinker. Its biological properties are optimized to avoid rapid renal clearance and maximize accumulation in macrophages within solid tissues and tumors.

Other names
64Cu-labeled polyglucose nanoparticle

Beyond the preview

Go deeper on [64Cu] Macrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [64Cu] Macrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call